Kjeldsen SE - Search Results

1

Cost-effectiveness of therapeutic drug monitoring in patients with resistant hypertension and improving patients' adherence.

Kjeldsen SE, Os I. Kjeldsen SE, et al. J Hypertens. 2014 Dec;32(12):2357-8. doi: 10.1097/HJH.0000000000000385. J Hypertens. 2014. PMID: 25376250 No abstract available.

2

1999 WHO/ISH Hypertension Guidelines--highlights & ESH update.

Kjeldsen SE, Erdine S, Farsang C, Sleight P, Mancia G; 1999 WHO/ISH Hypertension Guidelines subcommittee. Kjeldsen SE, et al. J Hypertens. 2002 Jan;20(1):153-5. doi: 10.1097/00004872-200201000-00022. J Hypertens. 2002. PMID: 11791039 No abstract available.

3

Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.

Kjeldsen SE, Hedner T, Syvertsen JO, Lund-Johansen P, Hansson L, Lanke J, Lindholm LH, De Faire U, Dahlöf B, Karlberg BE; NORDIL Study Group. Kjeldsen SE, et al. J Hypertens. 2002 Jun;20(6):1231-7. doi: 10.1097/00004872-200206000-00038. J Hypertens. 2002. PMID: 12023696 Clinical Trial.

4

Lower plasma noradrenaline and blood viscosity on carvedilol vs atenolol in men with recent myocardial infarction.

Jonsson G, Fossum E, Kjeldsen SE, Høieggen A, Os I, Eide I, Westheim A. Jonsson G, et al. Among authors: kjeldsen se. Blood Press. 2002;11(6):377-84. doi: 10.1080/080370502321095357. Blood Press. 2002. PMID: 12523682 Clinical Trial.

5

Hypertension in very old people.

Kjeldsen SE, Os I. Kjeldsen SE, et al. J Hypertens. 2003 Dec;21(12):2249-50. doi: 10.1097/00004872-200312000-00011. J Hypertens. 2003. PMID: 14654743 No abstract available.

6

Hypertension treatment and stroke prevention.

Kjeldsen SE, Fossum E, Reims HM, Høieggen A. Kjeldsen SE, et al. Blood Press. 2003;12(5-6):264-8. doi: 10.1080/08037050310016501. Blood Press. 2003. PMID: 14763656 Review. No abstract available.

7

Adrenal medullary overactivity in lean, borderline hypertensive young men.

Reims HM, Fossum E, Høieggen A, Moan A, Eide I, Kjeldsen SE. Reims HM, et al. Among authors: kjeldsen se. Am J Hypertens. 2004 Jul;17(7):611-8. doi: 10.1016/j.amjhyper.2004.03.676. Am J Hypertens. 2004. PMID: 15233980

8

Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide.

Kjeldsen SE, Os I, Høieggen A, Beckey K, Gleim GW, Oparil S. Kjeldsen SE, et al. Am J Cardiovasc Drugs. 2005;5(1):17-22. doi: 10.2165/00129784-200505010-00003. Am J Cardiovasc Drugs. 2005. PMID: 15631534 Review.

9

Renal hypertensive target organ damage--new evidence emerges in diabetics and smokers.

Kjeldsen SE, Os I, Hedner T, Himmelmann A. Kjeldsen SE, et al. Blood Press. 2004;13(6):324-5. doi: 10.1080/08037050410010416. Blood Press. 2004. PMID: 15771214 No abstract available.

10

A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients.

Jonsson G, Abdelnoor M, Müller C, Kjeldsen SE, Os I, Westheim A. Jonsson G, et al. Among authors: kjeldsen se. Cardiology. 2005;103(3):148-55. doi: 10.1159/000084584. Epub 2005 Mar 21. Cardiology. 2005. PMID: 15785019 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

693 results

Search Page